Title: [Rivaroxaban: Xarelto--recommendations for pharmacists]
Authors: Douxfils, J ×
Michel, S
Beauloye, C
Goethals, M
Hainaut, P
Heidbuchel, H
Hermans, C
Ickx, B
Jochmans, Koen
Mottes, S
Mullier, F
Peeters, A
Scavée, C
Sinnaeve, Peter
Sprynger, M
Thijs, Vincent
Vandenbroeck, C
Vandermeulen, E
Verhamme, Peter
Dogné, J M #
Issue Date: Mar-2013
Publisher: Association Pharmaceutique Belge
Series Title: Journal de Pharmacie de Belgique issue:1 pages:28-36
Abstract: Rivaroxaban is one of the new oral anticoagulants (NOACs). It has many potential advantages in comparison with Vitamin K Antagonists (VKA). It has a predictable anticoagulant effect and does not theoretically require biological monitoring. It is also characterized by less food and drug interactions. However, due to major risks associated with over- and under-dosage, its optimal use in patients should be carefully followed by health care professionals. The aim of this article is to provide recommendations for pharmacists on the practical use of Xarelto in its different approved indications. This document is adapted from the practical user guide of rivaroxaban which was developed by an independent group of Belgian experts in the field of thrombosis and haemostasis.
ISSN: 0047-2166
Publication status: published
KU Leuven publication type: AT
Appears in Collections:Laboratory for Neurobiology (Vesalius Research Center)
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.